NextPlat Corp (NXPL) FinancialsNXPLNextPlat Corp

NextPlat Corp (NXPL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pharmacy Prescription And Other Revenue Net Of Pbm Fees, accounting for 48.5% of total sales, equivalent to $4.78M. Other significant revenue streams include e-Commerce revenue and Pharmacy 340B contract revenue. Understanding this composition is critical for investors evaluating how NXPL navigates market cycles within the Wireless Telecommunications Services industry.

Evaluating the bottom line, NextPlat Corp maintains a gross margin of 38.84%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1.07%, while the net margin is -1.21%. These profitability ratios, combined with a Return on Equity (ROE) of -49.36%, provide a clear picture of how effectively NXPL converts its operational activities into shareholder value.

In the context of the broader market, NXPL competes directly with industry leaders such as AUST and BGL. With a market capitalization of $22.25M, it holds a leading position in the sector. When comparing efficiency, NXPL's gross margin of 38.84% stands against AUST's N/A and BGL's N/A. Such benchmarking helps identify whether NextPlat Corp is trading at a premium or discount relative to its financial performance.

NextPlat's gross margin has shown significant improvement, rising to 38.84% in Q2 2026 from 20.45% in Q2 2025, indicating better cost management and operational efficiency. Despite a decline in revenue, the company has managed to reduce its net loss significantly, with a net income loss of only $144,000 in Q2 2026 compared to larger losses in previous quarters.